Kim GY, Anderson KR, Davis DMR, Hand JL, Tollefson MM. Drug reaction with eosinophilia and systemic symptoms (DRESS) in the pediatric population: a systematic review of the literature. J Am Acad Dermatol. 2020;83(5):1323–30.

Article  CAS  PubMed  Google Scholar 

Afiouni R, Zeinaty P, Kechichian E, Zoghaib S, Matar S, Helou-Mallat J, et al. Pediatric drug reaction with eosinophilia and systemic symptoms: a systematic review of the literature, with a focus on relapsing cases. Pediatr Dermatol. 2021;38(1):125–31.

Article  PubMed  Google Scholar 

Metterle L, Hatch L, Seminario-Vidal L. Pediatric drug reaction with eosinophilia and systemic symptoms: a systematic review of the literature. Pediatr Dermatol. 2020;37(1):124–9.

Article  PubMed  Google Scholar 

Stirton H, Shear NH, Dodiuk-Gad RP. Drug reaction with eosinophilia and systemic symptoms (DReSS)/drug-induced hypersensitivity syndrome (DiHS)-readdressing the DReSS. Biomedicines. 2022;10(5):999.

Funck-Brentano E, Duong TA, Bouvresse S, Bagot M, Wolkenstein P, Roujeau JC, et al. Therapeutic management of DRESS: a retrospective study of 38 cases. J Am Acad Dermatol. 2015;72(2):246–52.

Article  PubMed  Google Scholar 

Schunkert EM, Divito SJ. Updates and insights in the diagnosis and management of DRESS syndrome. Curr Dermatol Rep. 2021;10(4):192–204.

Article  PubMed  PubMed Central  Google Scholar 

Chen YC, Chang CY, Cho YT, Chiu HC, Chu CY. Long-term sequelae of drug reaction with eosinophilia and systemic symptoms: a retrospective cohort study from Taiwan. J Am Acad Dermatol. 2013;68(3):459–65.

Article  PubMed  Google Scholar 

Ushigome Y, Kano Y, Ishida T, Hirahara K, Shiohara T. Short- and long-term outcomes of 34 patients with drug-induced hypersensitivity syndrome in a single institution. J Am Acad Dermatol. 2013;68(5):721–8.

Article  PubMed  Google Scholar 

Deng M, Wu H, Yu M, Tian Y, Li Y, Xiao X. Co-occurrence of multiple endocrine abnormalities induced by the DIHS/DRESS. Int J Endocrinol. 2019;2019:7959615.

Article  PubMed  PubMed Central  Google Scholar 

Tempark T, Deekajorndech T, Chatproedprai S, Supornsilchai V, Wananukul S. Late sequelae of drug reaction with eosinophilia and systemic symptoms (DRESS) cause thyroid dysfunction and thyroiditis: review of literature. J Pediatr Endocrinol Metab. 2022;35(5):567–75.

Article  CAS  PubMed  Google Scholar 

Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467–73.

Article  PubMed  Google Scholar 

Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap): a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377–81.

Article  PubMed  Google Scholar 

Kardaun SH, Sekula P, Valeyrie-Allanore L, Liss Y, Chu CY, Creamer D, et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study. Br J Dermatol. 2013;169(5):1071–80.

Article  CAS  PubMed  Google Scholar 

Cacoub P, Musette P, Descamps V, Meyer O, Speirs C, Finzi L, et al. The DRESS syndrome: a literature review. Am J Med. 2011;124(7):588–97.

Article  CAS  PubMed  Google Scholar 

Awad A, Goh MS, Trubiano JA. Drug reaction with eosinophilia and systemic symptoms: a systematic review. J Allergy Clin Immunol Pract. 2023;11(6):1856–68.

Article  CAS  PubMed  Google Scholar 

St George-Hyslop F, Cherepacha N, Chugani B, Alabdeen Y, Sanchez-Espino LF, Mahood Q, et al. Clinical presentation and diagnosis of drug reaction with eosinophilia and systemic symptoms (DReSS) in children: a scoping review. Clin Rev Allergy Immunol. 2024;66(1):112–23.

Article  PubMed  Google Scholar 

Shah SV, Vora NS, Dave JN, Goel R, Chakraborty N, Bhagat S. Phenytoin hypersensitivity syndrome. Indian J Dermatol Venereol Leprol. 1997;63(1):68–9.

CAS  PubMed  Google Scholar 

Hicks RA, Murphy JV, Jackson MA. Kawasaki-like syndrome caused by carbamazepine. Pediatr Infect Dis J. 1988;7(7):525–6.

Article  CAS  PubMed  Google Scholar 

Santos RP, Ramilo O, Barton T. Nevirapine-associated rash with eosinophilia and systemic symptoms in a child with human immunodeficiency virus infection. Pediatr Infect Dis J. 2007;26(11):1053–6.

Article  PubMed  Google Scholar 

Yoo SD, Kim SG, Kim SH, Kim HY. Drug rash with eosinophilia and systemic symptoms syndrome induced by chloral hydrate in early childhood. Allergy Asthma Immunol Res. 2014;6(3):270–2.

Article  PubMed  Google Scholar 

Bedouelle E, Ben Said B, Tetart F, Milpied B, Welfringer-Morin A, Maruani A, et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): series of 49 French pediatric cases. J Allergy Clin Immunol Pract. 2022;10(1):267-74.e5.

Article  CAS  PubMed  Google Scholar 

Verstegen RHJ, Phillips EJ, Juurlink DN. First-line therapy in drug reaction with eosinophilia and systemic symptoms (DReSS): thinking beyond corticosteroids. Front Med. 2023;10:1138464.

Article  Google Scholar 

Newell BD, Moinfar M, Mancini AJ, Nopper AJ. Retrospective analysis of 32 pediatric patients with anticonvulsant hypersensitivity syndrome (ACHSS). Pediatr Dermatol. 2009;26(5):536–46.

Article  PubMed  Google Scholar 

Aihara Y, Ito S, Aihara M, Kobayashi Y, Yokota S. Different patterns of cytokines, ECP and immunoglobulin profiles at two adverse drug reactions in a patient. Pediatr Int. 2005;47(6):616–21.

Article  PubMed  Google Scholar 

Aouam K, Ben Romdhane F, Loussaief C, Salem R, Toumi A, Belhadjali H, et al. Hypersensitivity syndrome induced by anticonvulsants: possible cross-reactivity between carbamazepine and lamotrigine. J Clin Pharmacol. 2009;49(12):1488–91.

Article  CAS  PubMed  Google Scholar 

Troost RJ, Oranje AP, Lijnen RL, Benner R, Prens EP. Exfoliative dermatitis due to immunologically confirmed carbamazepine hypersensitivity. Pediatr Dermatol. 1996;13(4):316–20.

Article  CAS  PubMed  Google Scholar 

Chaabane A, Aouam K, Fredj NB, Boughattas NA. DRESS syndrome : étude de 11 cas et revue de la littérature. Therapies. 2010;65(6):543–50.

Article  Google Scholar 

Ben Salem C, Slim R, Denguezli M, Nouira R, Hmouda H, Bouraoui K. A recurrent drug rash with eosinophilia and systemic symptoms. Pediatr Dermatol. 2007;24(6):666–8.

Article  PubMed  Google Scholar 

Semic-Jusufagic A, Ogese MO, Edwards C, Wilkinson M, Nissenbaum C, Lee T, et al. T-cell-mediated hypersensitivity to lumacaftor and ivacaftor in cystic fibrosis. Pediatr Allergy Immunol. 2022;33(6): e13815.

Article  CAS  PubMed  Google Scholar 

Mendiratta V, Bhushan P. Phenytoin-induced DRESS with cross-reactivity to carbamazepine in a 10-year-old Indian child. Clin Exp Dermatol. 2006;31(5):720–1.

Article  CAS  PubMed  Google Scholar 

Carroll MC, Yueng-Yue KA, Esterly NB, Drolet BA. Drug-induced hypersensitivity syndrome in pediatric patients. Pediatrics. 2001;108(2):485–92.

Article  CAS  PubMed  Google Scholar 

Mittal RR, Jain C, Walia RL, Chopra A. Drug-induced pseudolymphoma syndrome. Indian J Dermatol Venereol Leprol. 1995;61(2):94–5.

CAS  PubMed  Google Scholar 

Bessmertny O, Hatton RC, Gonzalez-Peralta RP. Antiepileptic hypersensitivity syndrome in children. Ann Pharmacother. 2001;35(5):533–8.

Article  CAS  PubMed  Google Scholar 

Chan AL. Pediatric fatality due to anticonvulsant hypersensitivity syndrome. Ann Pharmacother. 2003;37(6):918.

Article